NCT06557473View on ClinicalTrials.gov

Lidocaine Versus Fentanyl for Hemodynamic Stability

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

May 1, 2024

Study Completion Date

July 1, 2024

Conditions
HypertensionFentanylLidocaine
Interventions
DRUG

Lidocaine IV

1.5mg/kg IV for induction of GA

DRUG

Fentanyl

Fentanyl IV 2 µg/kg for GA induction

Trial Locations (1)

Unknown

Theodor Bilharz Research Institute, Giza

All Listed Sponsors
lead

Theodor Bilharz Research Institute

OTHER